Amcor plc (Form: 8-K, Received: 08/17/2021 16:17:49)

0001748790False00017487902021-08-172021-08-170001748790us-gaap:CommonStockMember2021-08-172021-08-170001748790amcr:GuaranteedSeniorNotesDue2027Member2021-08-172021-08-17

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 17, 2021


AMCOR PLC
(Exact name of registrant as specified in its charter)


Jersey	001-38932	98-1455367
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)


83 Tower Road North
Warmley, Bristol
United Kingdom			BS30 8XP
(Address of principal executive offices)			(Zip Code)


(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Ordinary Shares, par value $0.01 per share	AMCR	New York Stock Exchange
1.125% Guaranteed Senior Notes Due 2027	AUKF/27	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


☐			Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On August 17, 2021, Amcor plc (the “Company”) issued a press release regarding results for the fiscal year ended 2021. The press release is furnished as Exhibit 99.1 hereto. The Company is also furnishing an investor presentation relating to its fiscal year ended 2021 (the “Presentation”), which will be used by management for presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated into this Item 2.02 by reference. The Presentation is also available on the Company’s website at https://www.amcor.com/investors. The Company is not including the information contained on its website as part of, or incorporating it by reference into, this Current Report on Form 8-K.

The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 8.01 Other Events

On August 17, 2021, the Company’s Board of Directors approved a $400 million repurchase of the Company’s ordinary shares and/or the Company’s Chess Depositary Instruments (“CDIs”) over the next twelve months. Pursuant to this program, purchases of the Company’s ordinary shares and/or CDIs will be made subject to market conditions and at prevailing market prices, through open market purchases. The Company expects to complete the share buyback over the next twelve months; however, the timing, volume and nature of repurchases may be amended, suspended or discontinued at any time.

Item 9.01. Financial Statements and Exhibits.

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K (including the Exhibits hereto) contains certain statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. The Company has identified some of these forward-looking statements with words like “believe,” “may,” “could,” “would,” “might,” “possible,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “estimate,” “potential,” “outlook” or “continue,” the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of the Company, and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of the Company or any of its respective directors, executive officers or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause results to differ from expectations include, but are not limited to, those discussed in the Company’s disclosures described under Part I, "Item 1A - Risk Factors" in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Forward looking statements included herein are made only as of the date hereof and the Company does not undertake any obligation to update any forward-looking statements, or any other information in this Current Report on Form 8-K, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this Current Report on Form 8-K are qualified in their entirety by this cautionary statement.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		AMCOR PLC


Date	August 17, 2021	/s/ Damien Clayton
		Name:	Damien Clayton
		Title:	Company Secretary

Amcor reports record full year earnings and strong outlook for fiscal 2022

2021 Fiscal Year Highlights

•GAAP Net Income of $939 million, up 53%; GAAP earnings per share (EPS) of 60.2 cps, up 58%;

•Adjusted EPS of 74.4 cps, up 16% on a comparable constant currency basis, above guidance range;

•Adjusted Free Cash Flow of $1.1 billion, at upper end of guidance range;

•Bemis integration completed - financial targets exceeded and stronger foundation for growth: approximately $75 million of cost synergies in FY21 and expect total to exceed original $180 million target by at least 10%;

•Strong cash returns to shareholders: annual dividend increased to 47.0 cents per share, including 11.75 cents per share declared today. $350 million shares repurchased in FY21 (approximately 2% of outstanding shares);

•Accelerating sustainability agenda and delivery of responsible packaging solutions; and

•Fiscal 2022 outlook: Adjusted EPS growth of 7-11% on a comparable constant currency basis and Adjusted Free Cash Flow of $1.1-$1.2 billion. Allocating approximately $400 million of cash towards share repurchases.


An outstanding year, exceeding expectations
Amcor’s CEO Mr. Ron Delia said: "Amcor delivered record full year earnings in 2021, as our teams successfully executed against our strategy, delivered growth and increased EBIT margins while managing exceptionally well through steep raw material cost increases and supply constraints. EPS was 16% higher than last year, ahead of our upgraded guidance and we generated Free Cash Flow of $1.1 billion while increasing capital investments to generate future growth in our most attractive segments. The strong cash flow also enabled significant cash returns to shareholders through a higher annual dividend and the repurchase of shares. Across the business we ended the year with good momentum and we expect another strong year in fiscal 2022.” “In the two years following our transformational acquisition of Bemis, we have strengthened our financial profile and consistently built earnings momentum. The integration is essentially complete and we will exceed our original $180 million cost synergy target by at least 10% and Free Cash Flow for fiscal 2022 is expected to be almost double pre acquisition levels. Amcor is now better positioned strategically than ever with global scale, strong innovation capabilities and greater exposure to more attractive, higher growth end markets like healthcare and protein which offer more potential for differentiation and growth. This improved foundation will enable stronger growth and value creation for all stakeholders into the future.”


			Twelve Months Ended June 30,
GAAP results			2020 $ million	2021 $ million
Net sales			12,468	12,861
Net income			612	939
EPS (diluted US cents)			38.2	60.2

	Twelve Months Ended June 30,		Reported ∆%	Comparable constant currency ∆%
Adjusted non-GAAP results	2020 $ million	2021 $ million
Net sales(2)	12,468	12,861	3	2
EBITDA	1,913	2,028	6	6
EBIT	1,497	1,621	8	8
Net income	1,028	1,158	13	13
EPS (diluted US cents)	64.2	74.4	16	16
Free Cash Flow (before dividends)	1,220	1,099

(1) Adjusted non-GAAP results exclude items which are not considered representative of ongoing operations. Comparable constant currency ∆% excludes the impact of movements in foreign exchange rates and items affecting comparability. Further details related to non-GAAP measures and reconciliations to GAAP measures can be found under "Presentation of non-GAAP information” in this release.

(2) Comparable constant currency ∆% for net sales excludes a 2% favorable currency impact and a 1% unfavorable impact from items affecting comparability. There was no material impact from the pass through of raw material costs on comparable constant currency ∆% for net sales.

Note: All amounts referenced throughout this document are in US dollars unless otherwise indicated and numbers may not add up precisely to the totals provided due to rounding.

Bemis cost synergies

The Bemis Company was acquired through an all-stock transaction in June 2019.

Amcor continued to execute well against overhead, procurement and footprint initiatives and delivered approximately $75 million (pre-tax) of incremental cost synergies during fiscal 2021. Of this amount, approximately $65 million was recognized in the Flexibles segment and approximately $10 million in Other.

Combined with the $80 million delivered in fiscal 2020, cumulative costs synergies have reached approximately $155 million. Amcor expects to exceed the original target of $180 million by the end of fiscal 2022 by at least 10%.

Cash Returns to Shareholders

Amcor generates significant and growing Free Cash Flow, maintains strong credit metrics and is committed to an investment grade credit rating. This annual Free Cash Flow provides substantial capacity to simultaneously reinvest in the business, pursue acquisitions and return cash to shareholders through a compelling and growing dividend as well as share repurchases.

The Amcor Board of Directors today declared a quarterly cash dividend of 11.75 cents per share. Combined with the last three quarterly dividends, this increases the annual dividend for fiscal 2021 to 47.0 US cents per share. The quarterly dividend declared today will be paid in US dollars to holders of Amcor’s ordinary shares trading on the NYSE. Holders of CDIs trading on the ASX will receive an unfranked dividend of 15.93 Australian cents per share, which reflects the quarterly dividend of 11.75 cents per share converted at an average AUD:USD exchange rate of 0.7374 over the five trading days ended August 10, 2021.

The ex-dividend date will be September 7, 2021, the record date will be September 8, 2021 and the payment date will be September 28, 2021.

$350 million was used to repurchase shares in fiscal 2021 which reduced the total number of shares issued and outstanding by approximately 2%.

Amcor expects to allocate approximately $400 million of cash towards share repurchases in the 2022 fiscal year.

2021 financial results


	Twelve Months Ended June 30, 2020				Twelve Months Ended June 30, 2021
Adjusted non-GAAP results(1)	Net sales $ million	EBIT $ million	EBIT / Sales %	EBIT / Average funds employed %(2)	Net sales $ million	EBIT $ million	EBIT / Sales %	EBIT / Average funds employed %(2)
Flexibles	9,755	1,296	13.3		10,040	1,427	14.2
Rigid Packaging	2,716	284	10.4		2,823	299	10.6
Other	(3)	(83)			(2)	(105)
Total Amcor	12,468	1,497	12.0	14.0	12,861	1,621	12.6	15.4

(1) Adjusted non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to GAAP measures can be found under "Presentation of non-GAAP financial information” and in the tables included in this release.

(2) Average funds employed includes shareholders equity and net debt, calculated using a four quarter average and Last Twelve Months adjusted EBIT.

Full year net sales for the Amcor Group of $12,861 million were 2% higher than the prior year on a comparable constant currency basis. Overall volumes were 2% higher than the prior year and price/mix had no material impact on net sales.

EBIT margins increase by 60 basis points to 12.6% and return on average funds employed of 15.4% increased by 140 basis points compared with the prior year.


Flexibles	Twelve Months Ended June 30,		Reported ∆%	Comparable constant currency ∆%
	2020 $ million	2021 $ million
Net sales(1)	9,755	10,040	3	—
Adjusted EBIT	1,296	1,427	10	9
Adjusted EBIT / Sales %	13.3	14.2

(1) Comparable constant currency ∆% for Net sales excludes a 2% favorable currency impact, a 1% unfavorable impact from items affecting comparability (disposed businesses) and a 1% favorable impact from the pass though of raw material costs.

Net sales includes more than $100 million of price increases in the fourth quarter ending 30 June 2021, related to the pass through of higher raw material input costs.

Full year net sales on a comparable constant currency basis were marginally higher than the prior period with 1% higher volumes partially offset by price/mix.

Full year segment volume growth of 1% reflects strong growth across a range of higher value end markets including meat, coffee and pet food, which was mostly offset by lower volumes in certain healthcare end markets driven by fewer elective surgeries and prescriptions trends during the COVID-19 pandemic.

In North America, low single digit volume growth for fiscal 2021 was mainly driven by strength in the meat, frozen food and condiments end markets. This was partly offset by lower healthcare, home and personal care volumes.

In Europe, full year volumes were marginally lower than the same period last year with higher volumes in the pet food, cheese and coffee end markets offset by lower healthcare and yogurt volumes.

Full year volumes grew at mid-single digit rates across the Asian emerging markets, with double digit growth in both China and India, partly offset by lower volumes in South East Asia. In Latin America, fiscal 2021 volumes grew at low single digit rates compared with the prior period.

Adjusted EBIT for fiscal 2021 of $1,427 million was 9% higher than the prior period on a comparable constant currency basis. This includes 4% organic growth primarily reflecting higher volumes and outstanding margin management through the year. The remaining growth reflects approximately $65 million of cost synergy benefits related to the Bemis acquisition.

Adjusted EBIT margin expanded by 90 basis points to 14.2% compared with the prior year.


Rigid Packaging	Twelve Months Ended June 30,		Reported ∆%	Comparable constant currency ∆%
	2020 $ million	2021 $ million
Net sales(1)	2,716	2,823	4	8
Adjusted EBIT	284	299	6	8
Adjusted EBIT / Sales %	10.4	10.6

(1) Comparable constant currency ∆% for Net sales excludes a 3% unfavorable impact from the pass through of raw material costs and a 1% unfavorable currency impact.

Full year net sales on a comparable constant currency basis were 8% higher than the prior year. Overall volumes were 5% higher than the prior period with broad growth across North America and Latin America, and price/mix had a 3% favorable impact which includes pricing to recover cost inflation in Latin America.

In North America, full year beverage volumes were 8% higher than the prior year with hot fill container volumes up 13%. Growth was driven by rising consumer demand through the year which resulted in capacity shortages across the industry. Demand was particularly strong in hot fill categories including sports drinks, ready to drink tea and juice reflecting higher consumption and new product innovation in categories where the preferred package format is the PET container. Specialty container volumes were also higher than the prior year with good growth in the spirits, home and personal care categories, partly offset by lower healthcare volumes.

In Latin America, full year volumes were 5% higher than the prior year with sequential improvement in each quarter. Volumes grew in particular in Brazil and Argentina, partly offset by lower volumes in certain other markets in the region.

Adjusted EBIT for fiscal 2021 of $299 million was 8% higher than the prior year in comparable constant currency terms. Positive mix across the business and higher volumes were partly offset by increased labor and transportation costs incurred in North America to service rapidly increasing volume ahead of installing additional capacity.


Other	Twelve Months Ended June 30,
Adjusted EBIT	2020 $ million	2021 $ million
Equity earnings in affiliates, net of tax	12	3
Corporate expenses	(95)	(108)
Total Other	(83)	(105)

Net interest and income tax expense

Combined net interest and adjusted tax expense were broadly in line with last year. Net interest expense for the twelve months ended June 30, 2021 was $139 million compared with $185 million in the same period last year, with the decrease primarily driven by lower interest rates on floating rate debt. Offsetting this, adjusted tax expense for the twelve months ended June 30, 2021 (adjusted to exclude amounts related to non-GAAP adjustments) was $313 million compared with $276 million in the same period last year. Adjusted tax expense represents an effective tax rate of 21.1% in the current period (21.0% in the same period last year).

Adjusted Free Cash Flow for fiscal 2021 was $1,099 million. This is lower than the prior year as higher EBITDA growth was offset by the adverse impact from the timing of tax payments and a lower working capital benefit compared with fiscal 2020 when the business released more than $200 million of cash from working capital following the Bemis acquisition. Working capital performance remained strong through fiscal 2021 with Amcor's twelve month average working capital to sales ratio decreasing to 8%.

Net debt was $5,439 million at June 30, 2021, and leverage, measured as net debt divided by adjusted trailing twelve month EBITDA was 2.7 times.

Fiscal 2022 guidance

Amcor’s guidance contemplates a range of factors, however the COVID-19 pandemic creates higher degrees of uncertainty and additional complexity when estimating future financial results. For the twelve month period ending 30 June 2022, the Company expects:

•Adjusted EPS growth of approximately 7 to 11% on a comparable constant currency basis, or approximately 79.0 to 81.0 cents per share on a reported basis assuming current exchange rates prevail through fiscal 2022.

•Adjusted Free Cash Flow of approximately $1.1 to $1.2 billion.

•Approximately $400 million of cash to be allocated towards share repurchases.

While Amcor's business is expected to continue demonstrating resilience given it plays an important role in the supply of essential consumer goods, the level of earnings and Free Cash Flow generated across the business could be impacted by COVID-19 related factors such as the extent and nature of any future operational disruptions across the supply chain, government imposed restrictions on consumer mobility and the pace of macroeconomic recovery in key global economies. The ultimate magnitude and duration of the pandemic’s impact on the Company's business remains uncertain at this time.

Amcor is hosting a conference call with investors and analysts to discuss these results on Tuesday August 17, 2021 at 5:30pm US Eastern Daylight Time / Wednesday August 18, 2021 7:30am Australian Eastern Standard Time. Investors are invited to listen to a live webcast of the conference call at our website, www.amcor.com, in the “Investors” section.

Those wishing to access the call should use the following toll-free numbers, with the Conference ID 1892522:

•US & Canada – 866 211 4133

•Australia – 1800 287 011

•United Kingdom – 0800 051 7107

•Singapore – 800 852 6506

•Hong Kong – 800 901 563

From all other countries, the call can be accessed by dialing +1 647 689 6614 (toll).

A replay of the webcast will also be available on www.amcor.com following the call.

Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. Around 46,000 Amcor people generate $13 billion in annual sales from operations that span about 225 locations in 40-plus countries. NYSE: AMCR; ASX: AMC

www.amcor.com I LinkedIn I Facebook I Twitter I YouTube

Investors

Tracey Whitehead

Damien Bird

Head of Investor Relations

Vice President Investor Relations

Amcor

+61 3 9226 9028

+61 3 9226 9070

tracey.whitehead@amcor.com

damien.bird@amcor.com

Media - Australia

Media - Europe

Media - North America

James Strong

Ernesto Duran

Daniel Yunger

Head of Global Communications

Citadel-MAGNUS

Amcor

Kekst CNC

+61 448 881 174

+41 78 698 69 40

+1 212 521 4879

jstrong@citadelmagnus.com

ernesto.duran@amcor.com

daniel.yunger@kekstcnc.com

Amcor plc UK Establishment Address: 83 Tower Road North, Warmley, Bristol, England, BS30 8XP, United Kingdom

UK Overseas Company Number: BR020803

Registered Office: 3rd Floor, 44 Esplanade, St Helier, JE4 9WG, Jersey

Jersey Registered Company Number: 126984, Australian Registered Body Number (ARBN): 630 385 278

Cautionary Statement Regarding Forward-Looking Statements

This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like “believe,” “expect,” “target,” “project,” “may,” “could,” “would,” “approximately,” “possible,” “will,” “should,” “intend,” “plan,” “anticipate,” “estimate,” “potential,” “outlook,” or “continue,” the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers or advisors provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to: changes in consumer demand patterns and customer requirements, the loss of key customers, a reduction in production requirements of key customers; significant competition in the industries and regions in which Amcor operates; failure by Amcor to expand its business; failure to successfully integrate acquisitions; challenges to or the loss of Amcor’s intellectual property rights; adverse impacts from the ongoing COVID-19 pandemic; challenging future global economic conditions; impact of operating internationally; price fluctuations or shortages in the availability of raw materials and other inputs; disruptions to production, supply and commercial risks; a failure in our information technology systems; an inability to attract and retain key personnel; costs and liabilities related to current and future environmental and health and safety laws and regulations; labor disputes; foreign exchange rate risk; an increase in interest rates; a significant increase in indebtedness; failure to hedge effectively against adverse fluctuations in interest rates and foreign exchange rates; significant write-down of goodwill and/or other intangible assets; need to maintain an effective system of internal control over financial reporting; inability of the Company’s insurance policies to provide adequate protections; increasing scrutiny and changing expectations with respect to Amcor Environmental, Social and Governance policies resulting in increased costs; litigation, including product liability claims; changing government regulations in environmental, health and safety matters; changes in tax laws or changes in our geographic mix of earnings; and the Company’s ability to develop and successfully introduce new products; and other risks and uncertainties identified from time to time in Amcor’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including without limitation, those described under Item 1A. “Risk Factors” of Amcor’s annual report on Form 10-K for the fiscal year ended June 30, 2020 and any subsequent quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.

Presentation of non-GAAP information

Included in this release are measures of financial performance that are not calculated in accordance with U.S. GAAP. These measures include adjusted EBIT (calculated as earnings before interest and tax), adjusted net income, adjusted earnings per share, adjusted free cash flow and net debt. In arriving at these non-GAAP measures, we exclude items that either have a non-recurring impact on the income statement or which, in the judgment of our management, are items that, either as a result of their nature or size, could, were they not singled out, potentially cause investors to extrapolate future performance from an improper base. While not all inclusive, examples of these items include:

•material restructuring programs, including associated costs such as employee severance, pension and related benefits, impairment of property, plant, and equipment and other assets, accelerated depreciation, termination payments for contracts and leases, contractual obligations and any other qualifying costs related to the restructuring plan;

•material sales and earnings from disposed or ceased operations and any associated profit or loss on sale of businesses or subsidiaries;

•consummated and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for Amcor’s acquisition of Bemis;

•impairments in goodwill and equity method investments;

•material acquisition compensation and transaction costs such as due diligence expenses, professional and legal fees and integration costs;

•material purchase accounting adjustments for inventory;

•amortization of acquired intangible assets from business combinations;

•payments or settlements related to legal claims; and

•impacts from hyperinflationary accounting

Amcor also evaluates performance on a comparable constant currency basis, which measures financial results assuming constant foreign currency exchange rates used for translation based on the average rates in effect for the comparable prior-year period. In order to compute comparable constant currency results, we multiply or divide, as appropriate, current-year U.S. dollar results by the current-year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. We then adjust for other items affecting comparability. While not all inclusive, examples of items affecting comparability include the difference between sales or earnings in the current period and the prior period related to acquired, disposed or ceased operations. Comparable constant currency net sales performance also excludes the impact from passing through movements in raw material costs.

Management has used and uses these measures internally for planning, forecasting, and evaluating the performance of the Company’s reporting segments and certain of the measures are used as a component of Amcor’s board of directors’ measurement of Amcor’s performance for incentive compensation purposes. Amcor believes that these non-GAAP measures are useful to enable investors to perform comparisons of current and historical performance of the company. For each of these non-GAAP financial measures, a reconciliation to the most directly comparable U.S. GAAP financial measure has been provided herein. These non-GAAP financial measures should not be construed as an alternative to results determined in accordance with U.S. GAAP. The Company provides guidance on a non-GAAP basis as we are unable to predict with reasonable certainty the ultimate outcome and timing of certain significant forward-looking items without unreasonable effort. These items include but are not limited to the impact of foreign exchange translation, restructuring program costs, asset impairments, possible gains and losses on the sale of assets, and certain tax related events. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP earnings and cash flow measures for the guidance period.

Amcor has received a waiver from the ASX’s settlement operating rules, which will allow the Company to defer processing conversions between its ordinary share and CDI registers from September 7, 2021 to September 8, 2021 inclusive.

U.S. GAAP Condensed Consolidated Statements of Income (Unaudited)


	Twelve Months Ended June 30,
($ million)	2019	2020	2021
Net sales	9,458	12,468	12,861
Cost of sales	(7,659)	(9,932)	(10,129)
Gross profit	1,799	2,536	2,732
Selling, general and administrative expenses	(999)	(1,385)	(1,292)
Research and development expenses	(64)	(97)	(100)
Restructuring and related expenses, net	(131)	(115)	(94)
Other income, net	187	55	75
Operating income	792	994	1,321
Interest expense, net	(191)	(185)	(139)
Other non-operating income, net	3	16	11
Income from continuing operations before income taxes and equity in income (loss) of affiliated companies	604	825	1,193
Income tax expense	(172)	(187)	(261)
Equity in income (loss) of affiliated companies, net of tax	4	(14)	19
Income from continuing operations	436	624	951
Income (loss) from discontinued operations, net of tax(1)	1	(8)	—
Net income	437	616	951
Net income attributable to non-controlling interests	(7)	(4)	(12)
Net income attributable to Amcor plc	430	612	939
USD:EUR FX rate	0.8767	0.9045	0.8385

Basic earnings per share attributable to Amcor plc	0.364	0.382	0.604
Diluted earnings per share attributable to Amcor plc	0.363	0.382	0.602
Weighted average number of shares outstanding – Basic	1,180	1,600	1,551
Weighted average number of shares outstanding - Diluted	1,184	1,602	1,556

(1) Represents loss generated from three former Bemis plants located in the United Kingdom and Ireland from July 1, 2019 to August 8, 2019. Amcor announced the disposal of these assets to Kohlberg & Company on June 25, 2019. This divestment was required by the European Commission at the time of approving Amcor’s acquisition of Bemis on February 11, 2019.

U.S. GAAP Condensed Consolidated Statements of Cash Flows (Unaudited)


	Twelve Months Ended June 30,
($ million)	2019	2020	2021
Net income	437	616	951
Depreciation, amortization and impairment	453	652	574
Changes in operating assets and liabilities	6	139	(47)
Other non-cash items	(120)	(23)	(17)
Net cash provided by operating activities	776	1,384	1,461
Purchase of property, plant and equipment and other intangible assets	(332)	(400)	(468)
Proceeds from sales of property, plant and equipment and other intangible assets	85	13	26
Proceeds from divestitures	216	425	214
Net debt (repayments) proceeds	(58)	126	(98)
Dividends paid	(680)	(761)	(742)
Share buy-back/cancellations	—	(537)	(351)
Other, including effects of exchange rate on cash and cash equivalents	(26)	(109)	65
Net (decrease) increase in cash and cash equivalents	(19)	141	107
Cash and cash equivalents at the beginning of the period	621	602	743
Cash and cash equivalents at the end of the period	602	743	850

U.S. GAAP Condensed Consolidated Balance Sheets (Unaudited)


($ million)	June 30, 2020	June 30, 2021
Cash and cash equivalents	743	850
Trade receivables, net	1,616	1,864
Inventories, net	1,832	1,991

Property, plant and equipment, net	3,615	3,761
Goodwill and other intangible assets, net	7,333	7,254
Other assets	1,303	1,468
Total assets	16,442	17,188
Trade payables	2,171	2,574
Short-term debt and current portion of long-term debt	206	103
Long-term debt, less current portion	6,028	6,186

Accruals and other liabilities	3,350	3,504
Shareholders equity	4,687	4,821
Total liabilities and shareholders equity	16,442	17,188

Reconciliation of Non-GAAP Measures

Reconciliation of adjusted Earnings before interest, tax, depreciation and amortization (EBITDA), Earnings before interest and tax (EBIT), Net income and Earnings per share (EPS)


	Twelve Months Ended June 30, 2020				Twelve Months Ended June 30, 2021
($ million)	EBITDA	EBIT	Net Income	EPS (Diluted US cents)	EBITDA	EBIT	Net Income	EPS (Diluted US cents)
Net income attributable to Amcor	612	612	612	38.2	939	939	939	60.2
Net income attributable to non-controlling interests	4	4			12	12
Loss from discontinued operations	8	8	8	0.5	—	—	—	—
Tax expense	187	187			261	261
Interest expense, net	185	185			139	139
Depreciation and amortization	607				572
EBITDA, EBIT, Net income and EPS	1,603	996	620	38.7	1,923	1,351	939	60.2
Material restructuring and related costs(1)	106	106	102	6.3	88	88	88	5.7
Impairment in equity method investments	26	26	26	1.6	—	—	—	—
Net gain on disposals(2)	—	—	—	—	(9)	(9)	(9)	(0.6)
Material transaction and other costs(3)	145	145	145	9.2	7	7	7	0.5
Material impact of hyperinflation	28	28	28	1.7	19	19	19	1.2

Pension settlements	5	5	5	0.3	—	—	—	—
Amortization of acquired intangibles(4)		191	191	12.0		165	165	10.6
Tax effect of above items			(89)	(5.6)			(51)	(3.2)
Adjusted EBITDA, EBIT, Net income and EPS	1,913	1,497	1,028	64.2	2,028	1,621	1,158	74.4

Reconciliation of adjusted growth to comparable constant currency growth
% growth - Adjusted EBITDA, EBIT, Net income and EPS					6	8	13	16
% items affecting comparability(5)					1	1	1	1
% currency impact					(1)	(1)	(1)	(1)
% comparable constant currency growth					6	8	13	16

(1) The twelve months ended June 30, 2021 includes a $51 million gain realized upon disposal of a non-core European hospital supplies business as part of optimizing its portfolio under the Bemis Integration restructuring plan.

(2) Includes $15 million gain realized upon disposal of AMVIG and losses on disposal of other non-core businesses.

(3) Includes costs associated with the Bemis acquisition. The twelve months ended June 30, 2021 includes a $19 million benefit related to Brazil indirect taxes. The twelve months ended June 30, 2020 includes $58 million of acquisition related inventory fair value step-up costs.

(4) The twelve months ended June 30, 2020 includes $26 million of sales backlog amortization related to the Bemis acquisition.

(5) Reflects the impact of disposed businesses.

Reconciliation of adjusted EBIT by reporting segment


	Twelve Months Ended June 30, 2020							Twelve Months Ended June 30, 2021
($ million)	Flexibles		Rigid Packaging		Other(1)	Total		Flexibles		Rigid Packaging		Other(1)	Total
Net income attributable to Amcor						612							939
Net income attributable to non-controlling interests						4							12
(Income) loss from discontinued operations						8							—
Tax expense						187							261
Interest expense, net						185							139
EBIT	970		210		(184)	996		1,142		253		(44)	1,351
Material restructuring and related costs(2)	63		38		5	106		126		20		(58)	88
Impairment in equity method investments	—		—		26	26		—		—		—	—
Net (gain) loss / on disposals(3)	—		—		—	—		6		—		(15)	(9)
Material transaction and other costs(4)	77		3		65	145		(7)		2		12	7
Material impact of hyperinflation	—		28		—	28		—		19		—	19

Pension settlements	—		—		5	5		—		—		—	—
Amortization of acquired intangibles(5)	186		5		—	191		160		5		—	165
Adjusted EBIT(6)	1,296		284		(83)	1,497		1,427		299		(105)	1,621
Adjusted EBIT / sales %	13.3	%	10.4	%		12.0	%	14.2	%	10.6	%		12.6	%
Reconciliation of adjusted growth to comparable constant currency growth
% growth - Adjusted EBIT								10		6			8
% items affecting comparability(7)								—		—			1
% currency impact								(1)		2			(1)
% comparable constant currency growth								9		8			8

(1) Other includes equity in income (loss) of affiliated companies, net of tax and general corporate expenses.

(2) The twelve months ended June 30, 2021 includes a $51 million gain realized upon disposal of a non-core European hospital supplies business as part of optimizing its portfolio under the Bemis Integration restructuring plan.

(3) Includes $15 million gain realized upon disposal of AMVIG and losses on disposal of other non-core businesses.

(4) Includes costs associated with the Bemis acquisition. The twelve months ended June 30, 2021 includes a $19 million benefit related to Brazil indirect taxes. The twelve months ended June 30, 2020 includes $58 million of acquisition related inventory fair value step-up costs.

(5) The twelve months ended June 30, 2020 includes $26 million of sales backlog amortization related to the Bemis acquisition.

(6) During the first quarter of fiscal 2021, the Company reported that it revised the presentation of the reportable segments adjusted EBIT to include an allocation of certain research and development and selling, general and administrative expenses that management previously reflected in Other. Prior periods have been recast to conform to the new cost allocation methodology.

(7) Reflects the impact of disposed businesses.

Reconciliations of adjusted Free Cash Flow


	Twelve Months Ended June 30,
($ million)	2020	2021
Net cash provided from operating activities	1,384	1,461
Purchase of property, plant and equipment and other intangible assets	(400)	(468)
Proceeds from sales of property, plant and equipment and other intangible assets	13	26
Operating cash flow related to divested operations	60	—
Material transaction and integration related costs	163	80
Adjusted Free Cash Flow(1)	1,220	1,099

(1) Adjusted Free Cash Flow excludes material transaction and integration related costs because these cash flows are not considered to be directly related to ongoing operations.


	Twelve Months Ended June 30,
($ million)	2020	2021
Adjusted EBITDA	1,913	2,028
Interest paid, net	(187)	(131)
Income tax paid(1)	(209)	(321)
Purchase of property, plant and equipment and other intangible assets	(400)	(468)
Proceeds from sale of property, plant and equipment and other intangible assets	13	26
Movement in working capital	213	29
Other	(123)	(64)
Adjusted Free Cash Flow(2)	1,220	1,099

(1) The twelve months ended June 30, 2020 excludes tax cash paid of $95 million related to disposal proceeds from divestments which were required by the European Commission and the U.S. Department of Justice at the time of approving Amcor’s acquisition of Bemis.

(2) Adjusted Free Cash Flow excludes material transaction and integration related costs because these cash flows are not considered to be directly related to ongoing operations.

Reconciliation of net debt


($ million)	June 30, 2020		June 30, 2021
Cash and cash equivalents	(743	)	(850	)
Short-term debt	195		98
Current portion of long-term debt	11		5
Long-term debt excluding current portion of long-term debt	6,028		6,186
Net debt	5,491		5,439

August 17, 2021 US August 18, 2021 Australia Ron Delia CEO Michael Casamento CFO FY21 Full Year Results NYSE: AMCR | ASX: AMC Exhibit 99.2

Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like “believe,” “expect,” “target,” “project,” “may,” “could,” “would,” “approximately,” “possible,” “will,” “should,” “intend,” “plan,” “anticipate,” “estimate,” “potential,” “outlook,” or “continue,” the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers or advisors provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to: changes in consumer demand patterns and customer requirements, the loss of key customers, a reduction in production requirements of key customers; significant competition in the industries and regions in which Amcor operates; failure by Amcor to expand its business; failure to successfully integrate acquisitions; challenges to or the loss of Amcor’s intellectual property rights; adverse impacts from the ongoing COVID-19 pandemic; challenging future global economic conditions; impact of operating internationally; price fluctuations or shortages in the availability of raw materials and other inputs; disruptions to production, supply and commercial risks; a failure in our information technology systems; an inability to attract and retain key personnel; costs and liabilities related to current and future environmental and health and safety laws and regulations; labor disputes; foreign exchange rate risk; an increase in interest rates; a significant increase in indebtedness; failure to hedge effectively against adverse fluctuations in interest rates and foreign exchange rates; significant write-down of goodwill and/or other intangible assets; need to maintain an effective system of internal control over financial reporting; inability of the Company’s insurance policies to provide adequate protections; increasing scrutiny and changing expectations with respect to Amcor Environmental, Social and Governance policies resulting in increased costs; litigation, including product liability claims; changing government regulations in environmental, health and safety matters; changes in tax laws or changes in our geographic mix of earnings; and the Company’s ability to develop and successfully introduce new products; and other risks and uncertainties identified from time to time in Amcor’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including without limitation, those described under Item 1A. “Risk Factors” of Amcor’s annual report on Form 10-K for the fiscal year ended June 30, 2020 and any subsequent quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement. Presentation of non-GAAP information Included in this release are measures of financial performance that are not calculated in accordance with U.S. GAAP. These measures include adjusted EBIT (calculated as earnings before interest and tax), adjusted net income, adjusted earnings per share, adjusted free cash flow and net debt. In arriving at these non-GAAP measures, we exclude items that either have a non-recurring impact on the income statement or which, in the judgment of our management, are items that, either as a result of their nature or size, could, were they not singled out, potentially cause investors to extrapolate future performance from an improper base. While not all inclusive, examples of these items include: • material restructuring programs, including associated costs such as employee severance, pension and related benefits, impairment of property and equipment and other assets, accelerated depreciation, termination payments for contracts and leases, contractual obligations, and any other qualifying costs related to the restructuring plan; • material sales and earnings from disposed or ceased operations and any associated profit or loss on sale of businesses or subsidiaries; • consummated and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for Amcor’s acquisition of Bemis; • impairments in goodwill and equity method investments; • material acquisition compensation and transaction costs such as due diligence expenses, professional and legal fees, and integration costs; • material purchase accounting adjustments for inventory; • amortization of acquired intangible assets from business combinations; • payments or settlements related to legal claims; and • impacts from hyperinflation accounting. Amcor also evaluates performance on a comparable constant currency basis, which measures financial results assuming constant foreign currency exchange rates used for translation based on the average rates in effect for the comparable prior- year period. In order to compute comparable constant currency results, we multiply or divide, as appropriate, current-year U.S. dollar results by the current-year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. We then adjust for other items affecting comparability. While not all inclusive, examples of items affecting comparability include the difference between sales or earnings in the current period and the prior period related to acquired, disposed or ceased operations. Comparable constant currency net sales performance also excludes the impact from passing through movements in raw material costs. Management has used and uses these measures internally for planning, forecasting and evaluating the performance of the Company’s reporting segments and certain of the measures are used as a component of Amcor’s board of directors’ measurement of Amcor’s performance for incentive compensation purposes. Amcor believes that these non-GAAP measures are useful to enable investors to perform comparisons of current and historical performance of the Company. For each of these non-GAAP financial measures, a reconciliation to the most directly comparable U.S. GAAP financial measure has been provided herein. These non-GAAP financial measures should not be construed as an alternative to results determined in accordance with U.S. GAAP. The Company provides guidance on a non-GAAP basis as we are unable to predict with reasonable certainty the ultimate outcome and timing of certain significant forward-looking items without unreasonable effort. These items include but are not limited to the impact of foreign exchange translation, restructuring program costs, asset impairments, possible gains and losses on the sale of assets and certain tax related events. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP earnings and cash flow measures for the guidance period.

Safety 3 • 23% reduction in number of injuries • 53% of sites injury free for >12 months Committed to our goal of ‘no injuries’ 11.2 4.1 2.0 2.8 2.2 0.4 Recordable-case frequency rate (per million hours worked) 2021 OSHA Includes impact of acquired businesses 2021201520102005 2020 Notes: Recordable cases per 1,000,000 hours worked. All data shown for a 12 month period ended June 30. Acquired businesses (including Bemis) are included in 2020 and account for the increase in frequency rate compared with 2015 Amcor equivalent under OSHA (Occupational Safety & Health Administration) standards Amcor Values

Key messages for today 4 1. FY21: An outstanding year on multiple dimensions 2. Momentum building - expect another strong year in FY22 3. Bemis integration complete, exceeding expectations, stronger foundation 4. Investing behind organic growth drivers, including sustainability

FY21: Outstanding financial results and ahead of expectations 5 Revenue +2% EBIT EBIT margin +60bps Notes: EPS, EBIT and EBIT margin presented on an adjusted basis. Adjusted non-GAAP measures exclude items which are not considered representative of ongoing operations. Revenue, EBIT and EPS growth rates expressed in comparable constant currency terms which excludes the impact of movements in foreign exchange rates and items affecting comparability. RoAFE reflects Adjusted EBIT / Average funds employed (four quarter average). Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section. EPS +16%+8% RoAFE of 15.4% >$1 billion cash returned to shareholders Record earnings. Exceptional margin management. Carrying momentum into FY22 Free Cash Flow $1,621M $1.1 bn12.6% 74.4 cents$12,861M

Full Year Highlights • Record annual sales and EBIT • Adjusted EBIT growth 9% • 4Q21 net sales includes price increases of >$100 million related to higher raw material costs • 4Q21 EBIT margin expansion of 40 bps; FY21 EBIT margin expansion of 90 bps to 14.2% • Segment volumes 1% higher • MSD growth in meat, pet food and coffee • DD growth in China and India • Offset by DD decline in healthcare volumes Flexibles segment 6 Notes: Non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures including Adjusted EBIT and reconciliations to U.S. GAAP measures can be found in the appendix. Comparable constant currency Δ% for Net sales excludes a 2% favorable currency impact, a 1% unfavorable impact from items affecting comparability (disposed businesses) and a 1% favorable impact from the pass through of raw material costs. MSD is ‘Mid-Single Digit’ and DD is ‘Double digit’. Strong execution, margin expansion and earnings growth FY20 FY21 Comparable constant currency Net sales 9,755 10,040 - Adjusted EBIT ($m) 1,296 1,427 +9% Adjusted EBIT margin 13.3% 14.2% Raw materials by weight Raw materials consumption: diversified by material and geography

Rigid Packaging segment 7 Notes: Non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures including Adjusted EBIT and reconciliations to U.S. GAAP measures can be found in the appendix. Comparable constant currency Δ% for Net sales excludes a 3% unfavorable impact from the pass through of raw material costs and a 1% unfavorable currency impact. LRB references non-alcoholic Liquid Refreshment Beverage. Increasing consumer demand and strong earnings growth Full Year Highlights • Organic adjusted EBIT growth of 8% • Segment volume growth 5% and positive mix • North America – strong demand resulting in capacity shortages across the industry • Beverage volumes up 8% - hot fill up 13% • Specialty Container volumes higher • Latin America volumes up 5% • Acceleration of new product introductions with recycled resin to meet strong demand • Total recycled resin usage almost doubled in the last two years. FY20 FY21 Comparable constant currency Net sales 2,716 2,823 +8% Adjusted EBIT ($m) 284 299 +8% Adjusted EBIT margin 10.4% 10.6% 36.6% 37.1% 36.9% 36.2% 38.1% Q1 CY17 Q2 CY17 Q3 CY17 Q4 CY17 Q1 CY18 Q2 CY18 Q3 CY18 Q4 CY18 Q1 CY19 Q2 CY19 Q3 CY19 Q4 CY19 Q1 CY20 Q2 CY20 Q3 CY20 Q4 CY20 Q1 CY21 Q2 CY21 Consistent PET share in a growing US LRB market Source: IRI Calendar Year data (LRB retail sales in PET container format excluding still bottled water)

Cashflow, balance sheet & cash returns to shareholders 8 Notes: Non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures including Adjusted EBITDA and Adjusted Free Cash Flow and reconciliations to U.S. GAAP measures can be found in the appendix section. (1) Adjusted free cash flow excludes material transaction and integration related costs because these cash flows are not considered to be directly related to ongoing operations. (2) Leverage calculated as net debt divided by adjusted trailing twelve month EBITDA. Year to date cash flow ($ million) FY20 FY21 Adjusted EBITDA 1,913 2,028 Interest and tax payments (396) (452) Capital expenditure (400) (468) Movement in working capital 213 29 Other (110) (38) Adjusted Free Cash Flow(1) 1,220 1,099 Balance sheet(2) June 2021 Leverage: Net debt / LTM EBITDA (x) 2.7x • Growing EBITDA • Average working capital to sales of 8% • 3% reduction & ~$250m cash benefit since Bemis acquisition • Adverse timing of tax payments compared with last year • Increased capital spend on organic growth projects • Further increase of ~10-15% expected in FY22 • $1.1 billion cash returned to shareholders through: • Higher dividends per share; and • 2% of outstanding shares repurchased $1.1 billion adjusted free cash flow Balance sheet capacity to invest, execute M&A and return cash to shareholders Full Year Highlights

9 Note: Reconciliations of the FY22 projected non-GAAP measures are not included herein because the individual components are not known with certainty as individual financial statements for fiscal 2022 have not been completed. Guidance for fiscal year ending 30 June 2022 Amcor’s guidance contemplates a range of factors, including the COVID-19 pandemic which creates a higher degree of uncertainty and additional complexity when estimating future financial results. Refer to slide 2 for further information Adjusted EPS growth of approximately 7 to 11% on a comparable constant currency basis, or approximately 79.0 to 81.0 cents per share on a reported basis assuming current exchange rates prevail through fiscal 2022 Adjusted Free Cash Flow will increase to approximately $1.1 to $1.2 billion Approximately $400 million of cash to be allocated towards share repurchases For fiscal 2022 the Company expects:

10 Transformational Bemis acquisition exceeding expectations Enhancing financial performance…strengthening foundation for growth 10 Comprehensive global footprint in flexible packaging Greater exposure to attractive healthcare and protein end markets Enhanced innovation and sustainability capabilities Absolute and relative scale advantage in every region Cost synergies Notes: EPS and EBIT margin presented on an adjusted basis. Adjusted non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section. Based on expectations for fiscal 2022. Reconciliations of the fiscal 2022 projected non-GAAP measures are not included herein because the individual components are not known with certainty as individual financial statements for fiscal 2022 have not been completed. Stronger customer value proposition: ≥10% Expectations for FY22 (3rd year post closing): above original $180m target ~25% Shares repurchased of consideration shares issued +>21cps Earnings Per Share or >35% vs FY19 Flexibles EBIT margin >200bps vs FY19

Investing in multiple drivers of organic growth Higher Growth Segments Emerging Markets >$3 bn Emerging Markets business across 27 countries including: Investing in our innovation capabilities Innovation ProteinHealthcare Hot-fill beverage 11 Extending world class innovation center network into China & Europe and investing to develop the best talent in the industry MSD volume growth across all emerging markets with China and India up double digits in fiscal 2021 Investing in capacity More Sustainable Packaging… …to preserve food and healthcare products, protect consumers and promote brands Higher growth, higher value segments including: Notes: MSD is ‘Mid-Single Digit’.

Accelerating delivery of Responsible Packaging solutions 1212 Responsible Packaging: Waste management infrastructure Consumer participationPackaging design Commercialising new product platforms to meet increasing customer demand Collaboration across the value chain to set standards and drive global alignment PCR content Recyclable Compostable Recyclable paper Higher PCR usage in the last two years 2x PVC free

The Amcor investment case has never been stronger Global industry leader with proven track record and clear strategy Consistent growth from consumer and healthcare end markets Attractive and growing dividend with current yield >4% Growing cash flow and strong balance sheet provides sustainable capacity to invest Momentum building and investing for growth EPS growth + Dividend yield = 10-15% per year 13 Notes: A range of factors are contemplated when estimating future financial results. Refer to slide 2 for further information.

Key messages for today 14 1. FY21: An outstanding year on multiple dimensions 2. Momentum building - expect another strong year in FY22 3. Bemis integration complete, exceeding expectations, stronger foundation 4. Investing behind organic growth drivers, including sustainability

Appendix slides FY21 Full year results – supplementary schedules and reconciliations

Focused global portfolio 16 $12.9 bn combined sales by product type, end market and geography Notes: Reflects FY21 sales HPC is Home & Personal Care. North America 47% Western Europe 24% Emerging markets 26% ANZ 3% geography Food 44% Beverage 24% Healthcare 12% HPC 7% Other consumer 9% Other 4% end market Rigids 21% Flexibles 68% Cartons 9% Closures 2% product type

FX translation impact 17 EUR, 20-30% Other currencies(2), 20-30% USD, 45-55% EUR:USD Euro strengthened vs USD, Average USD to EUR rate FY21 0.8385 vs FY20 0.9045 USD million impact on FY adjusted net income 7% 20 Other currencies(2):USD Other currencies weighted average vs USD weakened for FY21 vs FY20 average rates USD million impact on FY adjusted net income (6%) (15) (1) Approximate range based on estimated combined adjusted net income by currency. (2) Includes all currencies other than USD and EUR. Total currency impact $ million Adjusted EBIT 7 Adjusted net income 5 Combined net income currency exposures(1) FY21 currency impact

Reconciliations of non-GAAP financial measures 18

Reconciliations of non-GAAP financial measures 19

Reconciliations of non-GAAP financial measures 20


Exhibit No.			Description
99.1			Fiscal Year Ended 202 1 , Earnings Press Release
99.2			Fiscal Year Ended 2021, Earnings Investor Presentation